Patents
Patents for C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
12/2007
12/25/2007US7312200 9-ketospinosyn derivatives
12/21/2007WO2007145282A1 Therapeutic or prophylactic agent for allergic dermatitis
12/21/2007WO2007106469A3 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
12/21/2007CA2655286A1 Therapeutic or prophylactic agent for allergic dermatitis
12/13/2007US20070287745 Laulimalide Analogs and Uses Thereof
12/12/2007CN101087745A Cyclopropanation process
12/05/2007EP1141358B1 STABLY TRANSFECTED CELLS FOR IDENTIFYING COMPOUNDS WHICH AFFECT STABILITY OF mRNA
12/05/2007CN100352766C Microporous crystalline zeolite material (zeolite ITQ-22), synthesis method thereof and use of same as a catalyst
11/2007
11/29/2007WO2007110705A3 Macrolide as inhibitors of mhc class ii
11/29/2007US20070276147 Synthesis of Oligomeric Epicatechin- and Catechin-Derived Procyanidins
11/27/2007US7301045 Method for preparing ester condensate
11/22/2007US20070270598 Process for one pot conversion of artemisinin into artelinic acid
11/21/2007CN101076336A Novel curcumin analogues and uses thereof
11/15/2007US20070265356 Aliphatically modified biodegradable block copolymers as thermogelling polymers
11/08/2007US20070259949 broad spectrum antibiotic activity, in particular, Gram-positive bacteria
11/07/2007CN101066964A Juglone possessing anti cancer activity and its prepn
11/06/2007CA2241666C Tricyclic compounds, their production and use
11/01/2007US20070255055 Epothilone derivatives
10/2007
10/30/2007US7288676 Arylphenyl-substituted cyclic ketoenols
10/30/2007US7288543 Opioid receptor antagonists
10/25/2007DE102006018475A1 Verfahren zur Herstellung von Mumbaistatin-Derivaten A process for the production of Mumbaistatin derivatives
10/25/2007CA2634665A1 Crystalline polymorphic forms of olopatadine hydrochloride and processes for their preparation
10/24/2007EP1847540A1 Nouveaux dérivés d'épothilone, leur procédé de production et leur utilisation pharmaceutique
10/23/2007CA2185443C Method for the separation and purification of fullerenes
10/17/2007CN100343257C CCR1 antagonists for the treatment of I.A. demyelinating inflammatory disease
10/16/2007US7282598 Synthetic methods for preparing procyanidin oligomers
10/04/2007WO2007110761A2 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
10/04/2007WO2007098384A3 Tetracyclic steroid derivatives useful as progesterone receptor modulators
10/04/2007US20070232814 selective histamine H1-receptor antagonist; seasonal allergic conjunctivitis; large scale, cost effective, gives low level of impurities, eliminates the need to use the costly and dangerous base, butyllithium; ([(Z)-3-(dimethylamino)propylidene]-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid hydrochloride
10/04/2007CA2645791A1 Polymorphic forms of olopatadine hydrochloride and methods for producing olopatadine and salts thereof
10/03/2007EP1840216A2 Borrelidin-producing polyketides synthase and its uses
10/03/2007EP1840121A1 Glycine derivative and use thereof
09/2007
09/27/2007WO2007106997A1 Novel poly(ethylene oxide)-block-poly(ester) block copolymers
09/27/2007US20070225356 Preventive and/or Therapeutic Agent for Chronic Sinusitis
09/26/2007CN100339352C 2-and 2,5-substituted phenylketoenols
09/20/2007WO2007106469A2 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/20/2007US20070219381 New 1-Methoxy-2-Phenyl Ethenes Useful for the Preparation of 5-Carboxaldehyde-2-3-Dihydrobenzoxepines
09/20/2007CA2646430A1 Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
09/19/2007CN101037430A (-)-meptazinol double-ligand derivative and/or its salt and preparation method and usage
09/19/2007CN100337751C Hydroxylation of beta-dicarbonyls with zirconium catalysts
09/18/2007US7271297 Process for producing vinyl ether compounds
09/18/2007US7271264 Pentacyclic oxepines and derivatives thereof, compositions and methods
09/18/2007US7271176 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation
09/13/2007WO2007022089A3 Methods to identify therapeutic agents useful for treating and preventing atherosclerosis by counteracting the effect of cholesterol ozonation products
09/12/2007EP1831191A1 Chroman derivatives and their use as 5-ht receptor ligands
09/12/2007CN101033219A Macrolides compound of Macrolactin Q with antibacterial activity
09/11/2007US7268166 Substituted 4-phenyl amino butane; spinal chord injuries, neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics
09/07/2007WO2007084595A3 Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
09/06/2007US20070208075 Pharmaceutical compositions
09/05/2007EP1828087A1 Cyclopropanation process
08/2007
08/30/2007WO2007098384A2 Tetracyclic steroid derivatives useful as progesterone receptor modulators
08/30/2007US20070203346 Method for synthesizing epothilones and epothilone analogs
08/30/2007US20070203226 Calcium receptor antagonists; (R)-4-[(2-Indan-2-yl-1,1-dimethyl-ethylamino)-methyl]-6-oxo-2,5-dioxa-bicyclo[9.3.1]pentadeca-1(14),11(15),12-triene-14-carbonitrile; bone disorders; hypoparathyroidism, osteosarcoma, osteoarthritis, rheumatoid arthritis, Paget's disease, humoral , osteoporosis
08/30/2007CA2642763A1 Tetracyclic steroid derivatives useful as progesterone receptor modulators
08/29/2007EP1826196A2 Vinyl ether compounds
08/29/2007CN100334091C Degraded triterpenes and their production method and use
08/16/2007US20070191469 Novel tetracyclic tetrahydrofuran derivatives
08/15/2007CN1331848C Tricyclic steroid hormone nuclear receptor modulators
08/14/2007US7256178 Physiologically active substances
08/08/2007EP1814537A2 Macrocyclic tertiary amine beta-secretase inhibitors for the treatment of alzheimer's disease
08/02/2007US20070179135 Cannabinoid derivatives
08/02/2007US20070179129 Opioid receptor antagonists
07/2007
07/26/2007WO2007084595A2 Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
07/26/2007CA2637897A1 Carbocyclic and heterocyclic arylsulfones as gamma secretase inhibitors
07/25/2007EP1005465B1 New epothilone derivatives, method for producing same and their pharmaceutical use
07/17/2007US7244855 In presence of acidic clay; coupling in presenc eof silver tetrafluoroborate ; anticancer agents
07/12/2007WO2007077209A1 Radicicol derivatives useful for positron emission tomography
07/11/2007EP1805161A2 Isomigrastatin analogs in the treatment of cancer
07/11/2007EP1686983B1 Use of pentadienoic acid derivates for treatement of hyperuricemia
07/10/2007US7241755 E.g., pentamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-aza-13(Z)-cyclohexadecene-2,6-dione and 4S-[4R*,7S*,8R*,9R*,15R*(E)]]-4,8-dihydroxy-5,5,7,9,13,16-hexamethyl-16-[1-methyl-2-(2-methyl-4-thiazolyl)ethenyl]-1-oxa-13-cyclohexadecene-2,6-dione; antiproliferative agents
07/10/2007CA2370823C Metal catalysts and methods for making and using same
07/05/2007US20070155696 Efficiently producing a macrolide compound, in which a cyclodextrin is made to be present in a culture broth of actinomycetes; antitumor agents
07/03/2007US7238816 Preparation of epothilone derivatives
06/2007
06/28/2007US20070148744 inhibitors of vacuolar-type H+-ATPase; antibiotic; (3Z,5E,7R,8S,9S,11E,13E,15S,16R)-16- [(1S,2R,3S)-3-[(2R,4R,5S,6R)-2,4-dihydroxy-6- isopropyl-5-methyl-2-tetrahydropyranyl]-2- hydroxy-1-methylbutyl]-8-hydroxy-3,15- dimethoxy-5,7,9,11-tetramethyl-1- oxacyclohexadeca-3,5,11,13-tetraen-2-one
06/27/2007EP1799213A2 Novel curcumin analogues and uses thereof
06/21/2007US20070142253 9-Oxa-bicyclo[15.1.0]octadecan-8-one, bicyclo[14.1.0]heptadecan-8-one and 3-Methyl-6-oxa-bicyclo[13.1.0]hexadecane-7-one; creating fragrances, and scents in items such as perfumes, colognes and personal care products; novel cyclopropanated macrocyclic compounds
06/14/2007US20070135498 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxy-propoxy)-benzyl]-8-methyl-nonanoic acid (1-hydroxymethyl-cyclopentyl)-amide; hypertension, atherosclerosis, unstable coronary syndrome, congestive heart failure, cardiac hypertrophy, cardiac fibrosis, cardiomyopathy postinfarction, alzheimers
06/13/2007EP1794142A1 A novel compound and a novel microorganism for producing the novel compound
06/13/2007CN1980652A Medicament for preventing and/or treating sleep disorder
06/07/2007US20070129554 Alpha functionalization of cyclic, ketalized ketones and products therefrom
06/06/2007EP1791823A1 Antibiotic and method for production thereof
06/06/2007CN1976914A 11-methyl-13-tridecanolide, 12-methyl-14-tetradeca- nolide and 13-methyl-15-pentadecanolide, perfume compositions containing the same, and process for the production of compounds including the same
06/05/2007CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues
05/2007
05/29/2007CA2197673C Drugs to improve synaptic transmission
05/23/2007EP1560576A4 Synthesis of oligomeric epicatechin and catechin-derived procyanidins
05/17/2007US20070111991 10,11-Dihydro-dibenzo[b,f]oxepine-10-carboxylic acid [(1S*,2S*,4R*)-4-butylcarbamoyl-2-hydroxy-1-(3-hydroxy-benzyl)-pentyl]-amide; treatment of neurological and vascular disorders related to beta-amyloid generation and/or aggregation
05/16/2007CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
05/09/2007CN1314679C Compound of substituted nonane oxide-2-ketone, preparation method and application
05/08/2007US7214705 Antiproliferative activity and is most unlikely a substrate for P-glycoprotein and/or Multidrug Resistant Protein
05/03/2007WO2007035734A3 Cytotoxin compounds and methods of isolation
05/03/2007US20070099854 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
05/02/2007EP1778665A1 Process for the preparation of 11-[(z)-3-(dimethylamino)propylidene]-6,11-dihydro-dibenz[b,e]oxepin-2-yl]acetic acid
05/02/2007EP1576160B1 Borrelidin-derivatives and their use in medicine
05/02/2007CN1956714A Alpha-aminoamide derivatives useful in the treatment of lower urinary tract disorders
04/2007
04/26/2007US20070092954 Production of polyketides
04/24/2007USRE39592 Solid composition for implantation into an animal of 17 beta -acetoxyestra-4,9,11-trien-3-one and Estra-1,3,5(10)-trien-3,17 beta -diol with 75:25-DL-lactide-glycolide Copolymer; biodegradable polymer
04/19/2007DE19630980B4 Etnangien, Herstellung, Verwendung und Produktionsstamm sorangium cellulosum DSM 11 028 Etnangien, production, use and Sorangium cellulosum production strain DSM 11028
04/18/2007CN1310904C Tricyclic alkylhydroxamates, their preparation and thier use as well proliferation inhibitors
04/11/2007CN1946393A Preventive and/or therapeutic agent for chronic sinusitis
04/10/2007US7202271 Fused pentacyclic polyethers
1 ... 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 ... 36